Published in J Gen Virol on July 01, 1979
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain (1988) 18.17
The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution. Nature (1989) 5.87
Classification of rhabdovirus proteins: a proposal. J Virol (1972) 5.54
Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature (1982) 5.50
Myristylation of picornavirus capsid protein VP4 and its structural significance. Nature (1987) 5.26
The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). J Gen Virol (1989) 3.53
The proteins of biologically active sub-units of vesicular stomatitis virus. J Gen Virol (1970) 3.44
Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2) Am J Med Genet (1996) 3.17
Dissection of vesicular stomatitis virus into the infective ribonucleoprotein and immunizing components. J Gen Virol (1970) 2.85
Serological relationships between different strains of vesicular stomatis virus. J Gen Virol (1972) 2.68
Kinetic tuning of myosin via a flexible loop adjacent to the nucleotide binding pocket. J Biol Chem (1998) 2.62
Assignment of the genome segments of bluetongue virus type 1 to the proteins which they encode. Virology (1984) 2.60
The ribonucleic acids of the infective and interfering components of vesicular stomatitis virus. J Gen Virol (1967) 2.57
Chemical basis of antigenic variation in foot-and-mouth disease virus. Nature (1984) 2.52
Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice. J Virol (1993) 2.50
3'-Terminal nucleotide sequences in the genome RNA of picornaviruses. Nature (1978) 2.40
Protein covalently linked to foot-and-mouth disease virus RNA. Nature (1977) 2.35
Location of the initiation site for protein synthesis on foot-and-mouth disease virus RNA by in vitro translation of defined fragments of the RNA. J Virol (1980) 2.34
Characterisation of a rotavirus.20b. Nature (1975) 2.21
A physico-chemical sub-grouping of the mammalian picornaviruses. J Gen Virol (1973) 2.08
A re-appraisal of the biochemical map of foot-and-mouth disease virus RNA. J Gen Virol (1978) 2.06
Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature (1987) 2.00
Poly(C) in animal viral RNAs. Nature (1974) 1.95
Sequence and location of the poly C tract in aphtho- and cardiovirus RNA. Nucleic Acids Res (1979) 1.95
Model for vesicular stomatitis virus. J Virol (1972) 1.92
Infective virus substructure from vesicular stomatitis virus. J Virol (1967) 1.89
The antigens of vesicular stomatitis virus. I. Separation and immunogenicity of three complement-fixing components. J Immunol (1966) 1.89
Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus. Nature (1990) 1.86
Surface structure of vesicular stomatitis virus. J Gen Virol (1969) 1.82
Further physicochemical characterization of Nodamura virus. Evidence that the divided genome occurs in a single component. J Gen Virol (1978) 1.78
A foot and mouth disease syndrome in pigs caused by an enterovirus. Nature (1968) 1.74
Molecular cloning of foot and mouth disease virus genome and nucleotide sequences in the structural protein genes. Nature (1981) 1.73
Antibody-complexed foot-and-mouth disease virus, but not poliovirus, can infect normally insusceptible cells via the Fc receptor. Virology (1993) 1.72
More precise location of the polycytidylic acid tract in foot and mouth disease virus RNA. J Virol (1978) 1.69
Presence of a covalently linked protein on calicivirus RNA. J Gen Virol (1978) 1.66
Antigenic differences between isolates of swine vesicular disease virus and their relationship to Coxsackie B5 virus. Nature (1973) 1.63
Differentiation of convalescent animals from those vaccinated against foot-and-mouth disease by a peptide ELISA. Vaccine (1999) 1.61
Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants. Nature (1987) 1.57
Specificity of IgM and IgG antibodies after challenge with antigenically related togaviruses. J Immunol (1974) 1.54
The location of the ploy(C) tract in the RNA of foot-and-mouth disease virus. J Gen Virol (1976) 1.52
Biochemical analysis of a virulent and an avirulent strain of foot-and-mouth disease virus. J Gen Virol (1977) 1.52
Heterogeneity of the genome-linked protein of foot-and-mouth disease virus. J Virol (1980) 1.50
Purification and identification of the RNA-dependent RNA polymerase of foot-and-mouth disease virus. J Gen Virol (1979) 1.50
Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients. Antimicrob Agents Chemother (2000) 1.50
Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. Neurodegeneration (1995) 1.45
Formaldehyde as an inactivant. Vaccine (1995) 1.42
Comparison of azabicyclic esters and oxadiazoles as ligands for the muscarinic receptor. J Med Chem (1991) 1.42
A multi-hit model for the neutralization of animal viruses. J Gen Virol (1978) 1.41
Mental health concerns of Canadian adolescents: a consumer's perspective. Can J Psychiatry (1996) 1.41
"Instant-mix" whole brain photon with neutron boost radiotherapy for malignant gliomas. Int J Radiat Oncol Biol Phys (1990) 1.40
Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavir. Clin Pharmacol Ther (1998) 1.40
Sleep habits and patterns of college students: a preliminary study. J Am Coll Health (2001) 1.40
Biochemical identification of viruses causing the 1981 outbreaks of foot and mouth disease in the UK. Nature (1981) 1.39
The antigens of vesicular stomatitis virus. II. The presence of two low molecular weight immunogens in virus suspensions. J Immunol (1966) 1.38
Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPR. Br J Pharmacol (1999) 1.38
Picornaviridae. Intervirology (1974) 1.36
Effects of posterior fossa decompression with and without duraplasty on Chiari malformation-associated hydromyelia. Neurosurgery (2000) 1.35
Autogenous vein grafting in femoropopliteal atherosclerosis: the limits of its effectiveness. Surgery (1979) 1.34
Buoyant density of picornaviruses in caesium salts. J Gen Virol (1971) 1.28
A comparative chemical and serological study of the full and empty particles of foot-and mouth disease virus. J Gen Virol (1975) 1.27
Host cell selection of antigenic variants of foot-and-mouth disease virus. J Gen Virol (1989) 1.26
Surface structure of foot-and-mouth disease virus. J Gen Virol (1969) 1.25
Differential precipitation of foot and mouth disease virus proteins made in vivo and in vitro by hyperimmune and virus particle guinea pig antisera. Virology (1981) 1.24
Current embryology and treatment of gastroschisis and omphalocele. Arch Surg (1966) 1.24
Tryptic peptide analysis of the structural proteins of vesicular stomatitis virus. J Gen Virol (1978) 1.24
Serological evidence for the association of Akabane virus with epizootic bovine congenital arthrogryposis and hydranencephaly syndromes in New South Wales. Aust Vet J (1975) 1.23
A model for vesicular exanthema virus, the prototype of the calicivirus group. J Gen Virol (1978) 1.22
Further evidence for multiple proteins in the foot-and-mouth disease virus particle. J Gen Virol (1971) 1.22
Comparison of the antibodies elicited by the individual structural polypeptides of foot-and mouth disease and polio viruses. J Gen Virol (1979) 1.22
Constitutive activation of a single effector pathway: evidence for multiple activation states of a G protein-coupled receptor. Mol Pharmacol (1996) 1.21
Biochemical mapping of the foot-and-mouth disease virus genome. J Gen Virol (1977) 1.21
A model for foot-and-mouth disease virus. J Gen Virol (1972) 1.19
Encephalomyocarditis virus antibodies in sera from apparently normal pigs. Vet Rec (1977) 1.19
Childhood bereavement and subsequent psychiatric disorder. Br J Psychiatry (1966) 1.19
Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin Exp Immunol (1999) 1.19
The antigens of vesicular stomatitis virus. 3. Structure and immunogenicity of antigens derived from the virion by treatment with Tween and ether. J Immunol (1967) 1.19
Immunological priming with synthetic peptides of foot-and-mouth disease virus. J Gen Virol (1985) 1.18
Foot-and-mouth disease virus particles contain replicase protein 3D. Proc Natl Acad Sci U S A (1994) 1.18
Absence of poly (A) from the infective RNA of Nodamura virus. J Gen Virol (1976) 1.18
Kinetic and spectroscopic evidence for three actomyosin:ADP states in smooth muscle. J Biol Chem (2000) 1.18
Molecular weight of rhinovirus ribonucleic acid. J Gen Virol (1970) 1.17
Immune response to uncoupled peptides of foot-and-mouth disease virus. Immunology (1987) 1.17
Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites. J Gen Virol (1989) 1.17
Inpatient diagnostic assessments: 1. Accuracy of structured vs. unstructured interviews. Psychiatry Res (2001) 1.17
Oligonucleotide mapping of picornavirus RNAs by two-dimensional electrophoresis. Virology (1976) 1.16
Treatment of elevated intracranial pressure in Reye syndrome. Ann Neurol (1978) 1.15
Physico-chemical evidence for the re-classification of the caliciviruses. J Gen Virol (1974) 1.14
A high density component in several vertebrate enteroviruses. J Gen Virol (1975) 1.14
Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents. J Gen Virol (1989) 1.13
Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides. Immunology (1990) 1.13
A study of the kinetics of protein and RNA synthesis induced by foot-and-mouth disease virus. Biochim Biophys Acta (1966) 1.12
The pectic enzymes of the mould Byssochlamys fulva. Biochem J (1949) 1.12
The structure and replication of calicivirus RNA. Nature (1978) 1.12
Isolation of a soluble and template-dependent foot-and-mouth disease virus RNA polymerase. Virology (1981) 1.12
A new model for virus ribonucleic acid replication. Nature (1965) 1.10
Moleculas aspects of the antigenic variation of swine vesicular disease and Coxsackie B5 viruses. J Gen Virol (1977) 1.10
Identification of native foot-and-mouth disease virus non-structural protein 2C as a serological indicator to differentiate infected from vaccinated livestock. Res Vet Sci (1995) 1.10
Recombinant vaccinia viruses as vaccines. Nature (1986) 1.10
Relationship of a virus from Tellina tenuis to infectious pancreatic necrosis virus. J Gen Virol (1977) 1.09
Early Homo erectus skeleton from west Lake Turkana, Kenya. Nature (1985) 1.09